• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L. DUAL COLLAPSER (FOR VALVE SIZE 25, 27); TISSUE HEART VALVE/ ACCESSORY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L. DUAL COLLAPSER (FOR VALVE SIZE 25, 27); TISSUE HEART VALVE/ ACCESSORY Back to Search Results
Model Number ICV1348
Device Problem Difficult to Fold, Unfold or Collapse (1254)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/30/2018
Event Type  malfunction  
Manufacturer Narrative
A complete manufacturing and material records review for the accessory has been performed.The results confirmed that the accessory satisfied all material, visual and performance standards required at the time of manufacture and release.
 
Event Description
The manufacturer received a notification on apr.25, 2018 involving a failure to implant.It was reported that the site experienced difficulty mounting the valve correctly with the holder and collapser.The site reported no patient impact and stated another valve and accessory kit were used.The valve and dual collapser have been sent for analysis.This report concerns the accessory kit.A related report livanova (b)(4) pertains to the aforementioned valve.
 
Manufacturer Narrative
The returned accessories appeared in general good conditions except the dual holder silicon cap that was found damaged.After decontamination, the accessories were visually inspected without highlight any particular elements of not conformity according to the specifications or pre-existing defects.A simulation of collapsing phases was performed in order to attempt to replicate the reported event, according to the indication included in the ifu (perceval ¿ sutureless aortic heart valve ¿ instructions for use ¿ ic0215001345 rev.J).For a complete investigation the simulation was performed with the returned valve and accessory kit.In addition, the collapsing simulation was repeated restoring the silicon cap of the returned holder in order to replicate the collapsing procedure with all the accessories having the correct configuration.The simulation of the valve collapsing, performed with the returned device and using the returned accessory kit (in both conditions as was and with the restored cap), was successfully completed according to the current procedure.No anomalous behaviors were observed during both the collapsing procedures.Based on the performed analysis, the reported issue is not related to factors intrinsic in the involved device (etq 2018-02462) or related accessories (etq 2018-02452).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DUAL COLLAPSER (FOR VALVE SIZE 25, 27)
Type of Device
TISSUE HEART VALVE/ ACCESSORY
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L.
strada crescentino snc
saluggia, vc 13040
IT  13040
MDR Report Key7546796
MDR Text Key109488564
Report Number3005687633-2018-00161
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 06/22/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberICV1348
Device Lot Number1705080066
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/24/2018
Initial Date Manufacturer Received 04/25/2018
Initial Date FDA Received05/25/2018
Supplement Dates Manufacturer Received05/24/2018
Supplement Dates FDA Received06/22/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-